#generics
Related Stories (2)
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Reuters
April 28, 2026India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
March 18, 2026Related Pages (4)
Novartis Q1 profit down on US generic erosion
Swiss drugmaker Novartis reported first-quarter core operating profit below market expectations on Tuesday, as generic competition for its top-selling heart drug Entresto weighed on sales. Quarterly
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
Take advantage of our newsletter subscription and stay informed on the go!
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
India's cheap weight-loss drugs could reshape global obesity fight
India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - the molecule behind Danish drugmaker Novo Nordisk's blockbuster weight-loss drugs Wegovy and Ozempic - e